Lymphatic Malformations - 1 Studies Found
| RECRUITING |
: Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. : Lymphatic Malformations : 2024-11-21 : In Stage 1: adult participants (?18 years of age) will receive dose 1 or dose 2 of alpelisib; pediatric participants (6-17 years of age) will recie |